Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,872.16
      -2.95%
      US Tech 100
      20,700.40
      -3.41%
      Dow Jones
      42,326.87
      -2.58%
      Brent Oil
      72.615
      -0.16%
      Bitcoin
      99,452.64
      -0.61%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Quince Therapeutics Inc (QNCX) Quote

      Quince Therapeutics Inc

      Quince Therapeutics Inc (QNCX)

      NASDAQ
      1.85
      0.01
      (0.54%)
      Closed December 18 4:00PM
      Delayed by 15 minutes
      1.93
      0.08
      (4.32%)
      After Hours: 7:36PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      1.93
      Bid
      1.85
      Ask
      1.99
      Volume
      168,423
      1.84 Day's Range 2.00
      0.5116 52 Week Range 2.45
      Market Cap
      84.923M
      Previous Close
      1.84
      Open
      1.95
      Last Trade
      850
      @
      1.93
      (formt)
      Last Trade Time
      Financial Volume
      $ 319,741
      VWAP
      1.8984
      Average Volume (3m)
      594,771
      Shares Outstanding
      44,001,643
      Dividend Yield
      -
      PE Ratio
      -2.73
      Earnings Per Share (EPS)
      -0.71
      Revenue
      -
      Net Profit
      -31.39M

      About Quince Therapeutics Inc

      Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug ... Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug Encapsulation, or AIDE, technology platform, which is a novel drug/device combination that uses an automated process designed to encapsulate a drug into the patient's own red blood cells. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      quincetx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Quince Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker QNCX. The last closing price for Quince Therapeutics was $1.84. Over the last year, Quince Therapeutics shares have traded in a share price range of $ 0.5116 to $ 2.45.

      Quince Therapeutics currently has 44,001,643 shares outstanding. The market capitalization of Quince Therapeutics is $80.96 million. Quince Therapeutics has a price to earnings ratio (PE ratio) of -2.73.

      Ask ADVFN Intelligence (AI)

      QNCX Latest News

      More News

      Form S-3 - Registration statement under Securities Act of 1933

      5 hours ago
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 14 2024
      Edgar (US Regulatory)

      Form SC 13D - General Statement of Acquisition of Beneficial Ownership

      November 13 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 13 2024
      Edgar (US Regulatory)

      Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

      Phase 3 NEAT clinical trial on track with 32 patients enrolled to date with majority of U.S. and European study sites now enrolling patients Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage...

      November 13 2024
      Business Wire

      Quince Therapeutics Presents Data from Prior Phase 3 ATTeST Clinical Trial at 2024 International Congress for Ataxia Research

      Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the...

      November 12 2024
      Business Wire

      Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting

      Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the...

      November 11 2024
      Business Wire

      Quince Therapeutics to Participate at Upcoming Investor Conferences

      Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that...

      October 14 2024
      Business Wire

      Quince Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

      Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that...

      September 03 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      August 21 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.06-3.015075376881.992.10971.81987861.95003304CS
      40.169.03954802261.772.451.682867641.98315659CS
      121.15147.4358974360.782.450.695947711.42749925CS
      261.23175.7142857140.72.450.51163613831.24055519CS
      520.756.91056910571.232.450.51162260211.20523961CS
      156-10-83.822296730911.9314.60.51164769642.60178503CS
      260-40.36-95.436273350742.29121.980.511645996913.70801765CS

      QNCX - Frequently Asked Questions (FAQ)

      What is the current Quince Therapeutics share price?
      The current share price of Quince Therapeutics is $ 1.93
      How many Quince Therapeutics shares are in issue?
      Quince Therapeutics has 44,001,643 shares in issue
      What is the market cap of Quince Therapeutics?
      The market capitalisation of Quince Therapeutics is USD 80.96M
      What is the 1 year trading range for Quince Therapeutics share price?
      Quince Therapeutics has traded in the range of $ 0.5116 to $ 2.45 during the past year
      What is the PE ratio of Quince Therapeutics?
      The price to earnings ratio of Quince Therapeutics is -2.73
      What is the reporting currency for Quince Therapeutics?
      Quince Therapeutics reports financial results in USD
      What is the latest annual profit for Quince Therapeutics?
      The latest annual profit of Quince Therapeutics is USD -31.39M
      What is the registered address of Quince Therapeutics?
      The registered address for Quince Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Quince Therapeutics website address?
      The website address for Quince Therapeutics is quincetx.com
      Which industry sector does Quince Therapeutics operate in?
      Quince Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      LITMSnow Lake Resources Ltd
      $ 0.7943
      (334.04%)
      		1.2B
      NUKKNukkleus Inc
      $ 50.68
      (326.60%)
      		54.52M
      PLRZPolyrizon Ltd
      $ 3.256
      (210.10%)
      		137.32M
      QMCOQuantum Corporation
      $ 60.085
      (153.31%)
      		22.66M
      VRARGlimpse Group Inc
      $ 3.1885
      (100.53%)
      		55.04M
      XCHXCHG Ltd
      $ 2.16
      (-90.74%)
      		11.2M
      FTELFitell Corporation
      $ 5.50
      (-85.67%)
      		1.69M
      XHGXChange TED Inc
      $ 0.754
      (-52.28%)
      		549.39k
      MHUAMeihua International Medical Technologies Company Ltd
      $ 0.2755
      (-43.82%)
      		8.86M
      RNAZTransCode Therapeutics Inc
      $ 3.915
      (-38.00%)
      		860.08k
      LITMSnow Lake Resources Ltd
      $ 0.7943
      (334.04%)
      		1.2B
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.3671
      (9.94%)
      		317.96M
      CGTXCognition Therapeutics Inc
      $ 0.58295
      (28.15%)
      		287.37M
      RGTIRigetti Computing Inc
      $ 10.684
      (-4.01%)
      		280.37M
      NVDANVIDIA Corporation
      $ 128.91
      (-1.14%)
      		277.36M

      QNCX Discussion

      View Posts
      TrendTrade2016 TrendTrade2016 4 weeks ago
      QNCX BIO BEAST
      👍️0
      TrendTrade2016 TrendTrade2016 4 weeks ago
      qncx breakout
      👍️0
      TrendTrade2016 TrendTrade2016 1 month ago
      QNCX BREAKING 1.8O KEY
      👍️0
      glenn1919 glenn1919 1 month ago
      QNCX...........................https://stockcharts.com/h-sc/ui?s=QNCX&p=W&b=5&g=0&id=p86431144783
      👍️0
      TrendTrade2016 TrendTrade2016 1 month ago
      QNCX READY TO GO AGAIN
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      QNCX FAST OUT OF THE GATE
      👍️0
      Laster Laster 2 months ago
      Really neat technology AIDE. Novel way of adding a drug into a patients own red blood cell.
      Really amazing if it works.
      Watching closely here. I think it ran too fast right now without any news.
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      WEEKLY PUSH
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      QNCX AGAIN OFF THAT DIP
      👍️0
      glenn1919 glenn1919 2 months ago
      QNCX.................https://stockcharts.com/h-sc/ui?s=QNCX&p=W&b=5&g=0&id=p86431144783
      👍️0
      gail gail 2 months ago
      moving back up now.
      👍️0
      glenn1919 glenn1919 2 months ago
      QNCX..........................https://stockcharts.com/h-sc/ui?s=QNCX&p=W&b=5&g=0&id=p86431144783
      👍️0
      gail gail 2 months ago
      in on the dip. hi t/t.
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      HERE WE GO
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      QNCX BIO BEAST
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      QNCX ON THE MOVE
      👍️0
      Viewmont Viewmont 4 months ago
      $QNCX Nice! https://finance.yahoo.com/news/quince-therapeutics-announces-lancet-neurology-110000014.html
      👍️0
      INFINITI INFINITI 4 months ago
      Quince Therapeutics Announces The Lancet Neurology Publication of Phase 3 ATTeST Clinical Trial Data Evaluating EryDex for the Treatment of Ataxia-Telangiectasia (A-T)

      Source
      👍️0
      Monksdream Monksdream 4 months ago
      QNCX new 52 week low
      👍️0
      Monksdream Monksdream 9 months ago
      QNCX
      👍️0
      Monksdream Monksdream 10 months ago
      QNCX under $2
      👍️0
      AKATITUS AKATITUS 1 year ago
      Slow climber
      👍️0
      Monksdream Monksdream 1 year ago
      QNCX under $2
      👍️0
      AKATITUS AKATITUS 1 year ago
      Bought some 1.10s
      See what happens
      👍️0
      knrorrel knrorrel 1 year ago
      News https://www.stocktitan.net/news/QNCX/quince-therapeutics-to-acquire-ery-del-sp-a-and-its-phase-3-asset-02yx0yj60e08.html
      👍️0
      AJ Freely AJ Freely 1 year ago
      $QNCX - Up 10% Pre-Market/ Current Price $1.75
      To Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia with No Currently Approved Treatments and Estimated $1+ Billion Peak Sales Opportunity
      👍️0
      AJ Freely AJ Freely 1 year ago
      $QNCX- Up 26% Pre-Market/ Current Price $1.24
      Echo Lake Capital Increase Offer to Acquire Quince Therapeutics
      Increases offer to $1.80 per share + CVR to receive 85% of the future net proceeds of Quince as part of the Lighthouse Pharmaceuticals transaction
      👍️0
      alchemytrader alchemytrader 2 years ago
      Happens. Dirty diluting CEOs
      👍️0
      Backstabbed Backstabbed 2 years ago
      Sorry to hear that
      👍️0
      alchemytrader alchemytrader 2 years ago
      not true. i lost my ass trying to swing PSFE HLBZ FUV. took a terrible loss after finally fiving up. Had i held on i would have lost 90-99% of my money.
      👍️0
      Backstabbed Backstabbed 2 years ago
      all about patience. they all run eventually
      👍️0
      alchemytrader alchemytrader 2 years ago
      congrats
      👍️0
      Backstabbed Backstabbed 2 years ago
      $QNCX - added today!
      👍️0
      Backstabbed Backstabbed 2 years ago
      nice. very low PPS here after it hit a high of $1.75 in PM last week
      👍️0
      Sirpeter Sirpeter 2 years ago
      Hi buddy...added it to watch
      👍️0
      Backstabbed Backstabbed 2 years ago
      $QNCX - News out!!! Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023
      👍️0
      tw0122 tw0122 2 years ago
      $1.33 running again
      👍️0
      saj saj 2 years ago
      Mid 1.3's nice pop on news
      👍️0
      makinezmoney makinezmoney 2 years ago
      $QNCX: Decent bounce move here..... now 0.74


      2 days now back to back....................... it was receding since Summer last ear and now finally going


      On WATCH


      GO $QNCX
      👍️0
      cash4 cash4 2 years ago
      https://www.otcmarkets.com/filing/html?id=15980132&guid=AKk-kW7ZRh7-B3h
      👍️0

      Your Recent History

      NASDAQ
      QNCX
      Quince Therapeutics
      Delayed Upgrade Clock